GlaxoSmithKline (Cambodia) Co.,Ltd

GSK is investing in scientific research and discovery to drive innovation and widen access. We are committed to ensure all our products are manufactured and distributed to the same high-quality standards – regardless of where they are in the world. By 2020 we want our medicines and vaccines to reach 80% of the Cambodian population.

Our products: Within our pharmaceuticals and vaccines businesses, we are focused on the delivery of medicines in six core areas: HIV and infectious diseases, oncology, immuno-inflammation, vaccines, respiratory and rare diseases.

Our people: We are actively expanding the local team with comprehensive training to build their skills and knowledge to engage effectively with our customers. All employees put our four values (patient focus, integrity, respect for people and transparency) at the heart of everything they do.

Our 20% reinvestment strategy: We reinvest 20% of in-country-profit directly into opportunities for local people through our NGOs partners, including training for midwives to help reduce deaths during childbirth, building primary healthcare facilities where services are limited and improving local knowledge of health and nutrition.

BACKGROUND

We are on a mission to help people: do more, feel better, live longer.

GSK is a science-led global healthcare company. We have three world-leading businesses that research, develop and manufacture innovative pharmaceutical, vaccine and consumer healthcare products. 

We are committed to widening access to our products, so more people can benefit, no matter where they live in the world or what they can afford to pay.